The Lalji Family ALS Award
The Lalji Family ALS Award is a global prize celebrating excellence in…
![Stay in [u]touch[/u]](/static/paper-plane.svg)
More patients eligible for treatment research through innovative study design
Due to a new trial design for treatment research, more ALS patients…
Amylyx Pharmaceuticals and TRICALS to collaborate on phase 3 clinical trial
Today, Amylyx Pharmaceuticals provided an update on its plans to advance its…
Retrotope announces initiation of RT001 study in people with ALS
Retrotope Inc has announced that the first participants have been enrolled in…
Virtual ENCALS meeting 2021
This year, ENCALS (European Network to Cure ALS) will be organising their…
New centres in Portugal and Spain join TRICALS network
We are very excited to announce that recently two new expert ALS…
Towards remote muscle strength measurements using a newly developed portable fixed dynamometer
Progressive muscle weakness is the hallmark of ALS. Evaluating muscle strength is…
Newsletter December 2020
2020 has been a difficult year for everyone. However, despite the many…
Reconsidering the ALSFRS-R for ALS clinical trials
Questionnaires, such as the ALS Functional Rating Scale (ALSFRS), play an important…
Summary of the 31st International Symposium on ALS/MND
Last week the 31st International Symposium on ALS/MND was held online. This…